本日 2 人 - 昨日 10 人 - 累計 19259 人

2008

  1. HOME >
  2. 2008
• 氏家 寛 妄想の生物学的機序 精神医学対話. 弘文堂, 東京 (2008) 19-33.

• 氏家 寛 ゲノム情報から物質依存脆弱性を予測する 日本神経精神薬理学雑誌 (2008) 28 11-18.

• 氏家 寛 アルコール依存症の分子遺伝学 日本アルコール・薬物医学会雑誌 (2008) 43 87-96 .

• 氏家 寛 性同一性障害の分子遺伝学的研究 基盤研究(C)研究成果報告書 . (2008)

• 氏家 寛,岸本真希子,本橋靖子,岡久祐子,小高辰也,稲田俊也,原野陸正,小宮山徳太郎, 堀 達,山田光彦, 関根吉統, 曽良一郎,岩田仲生, 伊豫雅臣,尾崎紀夫,黒田重利 薬物依存の新たな治療開発のための候補分子の探索 Dysbindin遺伝子の解析 平成19年度総括研究報告書 厚生労働科学研究費補助金(医薬品・ 医療機器等レギュラトリーサイエンス総合研究推進事業)研究 薬物依存の新たな治療開発のための候補分子の探索 Dysbindin遺伝子の解析 乱用薬物による神経毒性・依存症に対する診断・予防及び治療法 に関する研究. (2008) 88-96.

• 高木 学,氏家 寛,澤 明,神谷 篤 統合失調症の病態機構の解明遺伝因子の活用の可能性 Medical Scinece Digest (2008) 34 570-574 .

• Ujike H: Nomura A, Morita Y, Morio A, Okahisa Y, Kotaka T, Kodama M, Ishihara T, Kuroda S: Multiple genetic factors in olanzapine-induced weight gain in schizophrenia patients a cohort study. J Clin Psychiatry. (2008) 69 1416-1422 .

• Ujike H: Susceptibility Genes for Methamphetamine Use disorders J Neurochem (2008) 106 34-35 .

• Ujike H: Nomura A, Morita Y, Okahisa Y, Kotaka T, kodama M, Ishihara T, Kuroda S. Analyses of genetic factors in olanzapine-induced weight gain in schizophrenic patients Eur Neuropsychopharmacology, (2008) 18 S417.

• Albalushi T, Horiuchi Y, Ishiguro H, Koga M, Inada T, Iwata N, Ozaki N, Ujike H, Watanabe Y, Someya T, Arinami T: Replication study and meta-analysis of the genetic association of GRM3 gene polymorphisms with schizophrenia in a large Japanese case-control population. Am J Med Genet B Neuropsychiatr Genet. (2008) 147 392-396.

• Ezaki N, Nakamura K, Sekine Y, Thanseem I, Anitha A, Iwata Y, Kawai M, Takebayashi K, Suzuki K, Takei N, Iyo M, Inada T, Iwata N, Harano M, Komiyama T, Yamada M, Sora I, Ujike H, Mori N: Short allele of 5-HTTLPR as a risk factor for the development of psychosis in Japanese methamphetamine abusers. Ann N Y Acad Sci. (2008) 1139 49-56.

• Hashimoto T, Hashimoto K, Miyatake R, Matsuzawa D, Sekine Y, Inada T, Ozaki N, Iwata N, Harano M, Komiyama T, Yamada M, Sora I, Ujike H, Iyo M: Association study between polymorphisms in glutathione-related genes and methamphetamine use disorder in a Japanese population. Am J Med Genet B Neuropsychiatr Genet. (2008) 147B 1040-1046 .

• Ikeda M, Hikita T, Taya S, Uraguchi-Asaki J, Toyo-oka K, Wynshaw-Boris A, Ujike H, Inada T, Takao K, Miyakawa T, Ozaki N, Kaibuchi K, Iwata N: Identification of YWHAE, a gene encoding 14-3-3epsilon, as a possible susceptibility gene for schizophrenia. Hum Mol Genet. (2008) 17 3212-3222 .

• Ikeda M, Takahashi N, Saito S, Aleksic B, Watanabe Y, Nunokawa A, Yamanouchi Y, Kitajima T, Kinoshita Y, Kishi T, Kawashima K, Hashimoto R, Ujike H, Inada T, Someya T, Takeda M, Ozaki N, Iwata N: Failure to replicate the association between NRG1 and schizophrenia using Japanese large sample. Schizophr Res. (2008) 101 1-8 .

• Ishiguro H, Imai K, Koga M, Horiuchi Y, Inada T, Iwata N, Ozaki N, Ujike H, Itokawa M, Kunugi H, Sasaki T, Watanabe Y, Someya T, Arinami T: Replication study for associations between polymorphisms in the CLDN5 and DGCR2 genes in the 22q11 deletion syndrome region and schizophrenia. Psychiatr Genet. (2008) 18 255-256 .

• Kinoshita Y, Ikeda M, Ujike H, Kitajima T, Yamanouchi Y, Aleksic B, Kishi T, Kawashima K, Ohkouchi T, Ozaki N, Inada T, Harano M, Komiyama T, Hori T, Yamada M, Sekine Y, Iyo M, Sora I, Iwata N: Association study of the calcineurin A gamma subunit gene (PPP3CC) and methamphetamine-use disorder in a Japanese population. Ann N Y Acad Sci. (2008) 1139 57-62 .

• Kishi T, Ikeda M, Kitajima T, Yamanouchi Y, Kinoshita Y, Kawashima K, Inada T, Harano M, Komiyama T, Hori T, Yamada M, Iyo M, Sora I, Sekine Y, Ozaki N, Ujike H, Iwata N: Glutamate cysteine ligase modifier (GCLM) subunit gene is not associated with methamphetamine-use disorder or schizophrenia in the Japanese population. Ann N Y Acad Sci. (2008) 1139 63-69 .

• Kishi T, Ikeda M, Kitajima T, Yamanouchi Y, Kinoshita Y, Kawashima K, Inada T, Harano M, Komiyama T, Hori T, Yamada M, Iyo M, Sora I, Sekine Y, Ozaki N, Ujike H, Iwata N: Alpha4 and beta2 subunits of neuronal nicotinic acetylcholine receptor genes are not associated with methamphetamine-use disorder in the Japanese population. Ann N Y Acad Sci. (2008) 1139 70-82 .

• Kishi T, Ikeda M, Kitajima T, Yamanouchi Y, Kinoshita Y, Kawashima K, Inada T, Harano M, Komiyama T, Hori T, Yamada M, Iyo M, Sora I, Sekine Y, Ozaki N, Ujike H, Iwata N: Prostate apoptosis response 4 gene is not associated with methamphetamine-use disorder in the Japanese population. Ann N Y Acad Sci. (2008) 1139 83-88 .

• Kishimoto M, Ujike H, Okahisa Y, Kotaka T, Takaki M, Kodama M, Inada T, Yamada M, Uchimura N, Iwata N, Sora I, Iyo M, Ozaki N, Kuroda S: The Frizzled 3 gene is associated with methamphetamine psychosis in the Japanese population. Behav Brain Funct. (2008) 4 37 .

• Kishimoto M, Ujike H, Motohashi Y, Tanaka Y, Okahisa Y, Kotaka T, Harano M, Inada T, Yamada M, Komiyama T, Hori T, Sekine Y, Iwata N, Sora I, Iyo M, Ozaki N, Kuroda S: The dysbindin gene (DTNBP1) is associated with methamphetamine psychosis. Biol Psychiatry. (2008) 63 191-196.

• Kotaka T, Ujike H, Morita Y, Kishimoto M, Okahisa Y, Inada T, Harano M, Komiyama T, Hori T, Yamada M, Sekine Y, Iwata N, Iyo M, Sora I, Ozaki N, Kuroda S: Association study between casein kinase 1 epsilon gene and methamphetamine dependence. Ann N Y Acad Sci. (2008) 1139 43-48 .

• Morita Y, Ujike H, Tanaka Y, Kishimoto M, Okahisa Y, Kotaka T, Harano M, Inada T, Komiyama T, Hori T, Yamada M, Sekine Y, Iwata N, Iyo M, Sora I, Ozaki N, Kuroda S: The glycine transporter 1 gene (GLYT1) is associated with methamphetamine-use disorder. Am J Med Genet B Neuropsychiatr Genet. (2008) 147 54-58.

• Nunokawa A, Watanabe Y, Kitamura H, Kaneko N, Arinami T, Ujike H, Inada T, Iwata N, Kunugi H, Itokawa M, Ozaki N, Someya T: Large-scale case-control study of a functional polymorphism in the glutamate receptor, metabotropic 3 gene in patients with schizophrenia. Psychiatry Clin Neurosci. (2008) 62 239-240.

• Ohtsuki T, Horiuchi Y, Koga M, Ishiguro H, Inada T, Iwata N, Ozaki N, Ujike H, Watanabe Y, Someya T, Arinami T: Association of polymorphisms in the haplotype block spanning the alternatively spliced exons of the NTNG1 gene at 1p13.3 with schizophrenia in Japanese populations. Neurosci Lett. (2008) 435 194-197.

• Ohtsuki T, Koga M, Ishiguro H, Horiuchi Y, Arai M, Niizato K, Itokawa M, Inada T, Iwata N, Iritani S, Ozaki N, Kunugi H, Ujike H, Watanabe Y, Someya T, Arinami T: A polymorphism of the metabotropic glutamate receptor mGluR7 (GRM7) gene is associated with schizophrenia. Schizophr Res. (2008) 101 9-16.

• Okabe N, Sato T, Matsumoto Y, Ido Y, Terada S, Kuroda S: Clinical characteristics of patients with gender identity disorder at a Japanese gender identity disorder clinic. Psychiatry Res. (2008) 157 315-318.

• Otani K, Ujike H, Sakai A, Okahisa Y, Kotaka T, Inada T, Harano M, Komiyama T, Hori T, Yamada M, Sekine Y, Iwata N, Iyo M, Sora I, Ozaki N, Kuroda S: Reduced CYP2D6 activity is a negative risk factor for methamphetamine dependence. Neurosci Lett. (2008) 434 88-92.

• Uhl GR, Drgon T, Liu QR, Johnson C, Walther D, Komiyama T, Harano M, Sekine Y, Inada T, Ozaki N, Iyo M, Iwata N, Yamada M, Sora I, Chen CK, Liu HC, Ujike H, Lin SK: Genome-wide association for methamphetamine dependence convergent results from 2 samples. Arch Gen Psychiatry. (2008) 65 345-355 .